Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
University of Birmingham · National Institute for Health Research · +11 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
2,096
total citations
- FWCI
- 76.40
- Percentile
- 100%
- References
- 32
Citations per year
Authors
16- MJMatthew J. Armstrong
University of Birmingham, National Institute for Health Research, NIHR Birmingham Liver Biomedical Research Unit, Queen Elizabeth Hospital Birmingham
- PGPiers Gaunt
University of Birmingham, NIHR Birmingham Liver Biomedical Research Unit
- GPGuruprasad P. Aithal
University of Nottingham, NIHR Nottingham Digestive Diseases Biomedical Research Unit, Nottingham University Hospitals NHS Trust
- DBDarren Barton
National Institute for Health Research, NIHR Birmingham Liver Biomedical Research Unit, University of Birmingham
- DHDiana Hull
University of Birmingham, National Institute for Health Research, NIHR Birmingham Liver Biomedical Research Unit
Topics & keywords
Topics
Keywords
- Liraglutide
- Medicine
- Steatohepatitis
- Placebo
- Internal medicine
- Fatty liver
- Gastroenterology
- Clinical trial
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.